Privia Health Group Inc (PRVA) posted a 3.48% change over the last five days signaling a new trend

A new trading day began on Monday, with Privia Health Group Inc (NASDAQ: PRVA) stock price up 3.86% from the previous day of trading, before settling in for the closing price of $21.48. PRVA’s price has ranged from $15.92 to $24.30 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 20.87%. Meanwhile, its annual earnings per share averaged -30.86%. With a float of $106.24 million, this company’s outstanding shares have now reached $119.95 million.

Considering the fact that the conglomerate employs 1102 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 9.47%, operating margin of 0.77%, and the pretax margin is 1.41%.

Privia Health Group Inc (PRVA) Breakdown of a Key Holders of the stock

As we move forward, let’s examine how large-scale investors are investing in this stock of the Health Information Services Industry. The insider ownership of Privia Health Group Inc is 11.47%, while institutional ownership is 97.11%. The most recent insider transaction that took place on Sep 10 ’24, was worth 2,500,127. In this transaction Chief Executive Officer of this company sold 135,142 shares at a rate of $18.50, taking the stock ownership to the 247,771 shares. Before that another transaction happened on Sep 10 ’24, when Company’s Officer proposed sale 135,142 for $18.50, making the entire transaction worth $2,500,719.

Privia Health Group Inc (PRVA) Recent Fiscal highlights

According to the Wall Street analysts, stocks earnings will be around -30.86% per share during the next fiscal year.

Privia Health Group Inc (NASDAQ: PRVA) Trading Performance Indicators

Here are Privia Health Group Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.78. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.55. Likewise, its price to free cash flow for the trailing twelve months is 28.38.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.10, a number that is poised to hit 0.05 in the next quarter and is forecasted to reach 0.26 in one year’s time.

Technical Analysis of Privia Health Group Inc (PRVA)

Compared to the last year’s volume of 0.85 million, its volume of 0.59 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 63.98%. Additionally, its Average True Range was 0.86.

During the past 100 days, Privia Health Group Inc’s (PRVA) raw stochastic average was set at 86.97%, which indicates a significant increase from 68.69% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 37.79% in the past 14 days, which was lower than the 42.28% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $19.25, while its 200-day Moving Average is $18.97. Nevertheless, the first resistance level for the watch stands at $22.74 in the near term. At $23.17, the stock is likely to face the second major resistance level. The third major resistance level sits at $23.91. If the price goes on to break the first support level at $21.57, it is likely to go to the next support level at $20.83. Now, if the price goes above the second support level, the third support stands at $20.40.

Privia Health Group Inc (NASDAQ: PRVA) Key Stats

With a market capitalization of 2.65 billion, the company has a total of 120,001K Shares Outstanding. Currently, annual sales are 1,658 M while annual income is 23,080 K. The company’s previous quarter sales were 437,920 K while its latest quarter income was 3,540 K.